COVAXIN

The study is yet to be peer-reviewed

CDSCO puts in place system to fast track processing of application for clinical trial and approval for COVID-19 vaccines

Covaxin has received a certificate of Good Manufacturing Practice (GMP) compliance from the Hungarian authorities, Bharat Biotech…

According to a statement issued by the National Health Surveillance Agency of Brazil, Anvisa, its Collegiate Board recently took a…

The Government of India has been supplying vaccines free of cost to the states/UTs for administration to prioritised beneficiaries…

The price of each dose of Covishield amounts to Rs 215.25, and Covaxin Rs 225.75, including taxes

The move follows the release by Bharat Biotech of Phase 3 clinical trial results, which demonstrated efficacy and safety in nearly…

According to WHO guidelines, EUL is a procedure to streamline the process by which new or unlicensed products can be used during…

MEA Spokesperson Arindam Bagchi said India hopes that individual countries would increasingly recognise made-in-India vaccines

Covaxin was well-tolerated and the Data Safety Monitoring Board has not reported any safety concerns related to the vaccine, the…